Channel Sponsor - Coding/Billing/Collections

Sponsored by National Medical Billing Services | info@nationalASCbilling.com | (636) 273-6711

The evolving ASC reimbursement landscape — 3 Qs with CEO Dr. Joe Smith

Reflexion Health CEO Joe Smith, MD, PhD, spoke to Becker's ASC Review about the evolving healthcare reimbursement landscape.

Note: Responses were lightly edited for style.

Question: What are the biggest payer and reimbursement changes your ASC customers have experienced over the past two to three years? Are you seeing more risk-based contracts or price transparency in your market(s)?

Dr. Joe Smith: ASCs are dealing across a continuum — some are aggressively seeking risk-based contracts as they understand their businesses and see great opportunities to drive efficiencies and margin, while others are doing their homework now and getting ready for value-based/at-risk contracts in the near future. There is a growing and general appreciation that payers are moving away from fee for service, and the forward-thinking ASCs are looking to capitalize on this trend.

Q: Are you seeing more patients with high-deductible health plans in your market(s)? What is your strategy for working with those patients?

JS: Our solution is focused on keeping the patient at home, which means fewer outpatient visits, greatly decreased transportation costs and much less face-to-face clinic care. We encourage our clients to offer VERA at zero cost to the patient, therefore it doesn't apply to their deductible and avoids the out-of-pocket expenses that too-often [are] a barrier to care.

Q: How do you approach payer negotiations? What are your top pieces of advice to make sure they're successful?

JS: Payers today are transitioning on the quadruple win: enhancing patient experience, improving population health, reducing healthcare costs and improving the work life of healthcare practitioners. We focus on all four, which is key to our success.

More articles on coding, billing and collections:
GI leader to know: Dr. Naga Chalasani of the Indiana University School of Medicine
Isareli diagnostics company developing blood-based CRC test — 4 insights
The deal days of summer — Edgemont's Luke Mitchell on the past, present & future of GI PE investment

© Copyright ASC COMMUNICATIONS 2019. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.

 

Top 40 Articles from the Past 6 Months